Venture-stage investment
Early Bird Biotics
A gut-health platform building non-GMO next-generation biotics — with an initial consumer product targeting alcohol metabolism.
Consumer Health Gut health · Next-generation biotics
Early Bird Biotics — next-generation biotics for gut health.
The science · The story
A venture-stage stake in an established Australian programme.
Early Bird Biotics is building a gut-health platform of non-GMO next-generation biotics, with an initial consumer product targeting alcohol metabolism.
A Queensland University of Technology spinout.
Proto Axiom was a first investor alongside Era VC.
- Invested
- 2026
- Origin
- Queensland University of Technology
- Sector
- Consumer Health
- Modality
- Gut health · Next-generation biotics
Leadership
Independently led; see the company website for the full team.
Alexander Debney
Co-founder
Early Bird Biotics
Dan Cable
Co-founder
Early Bird Biotics
Programme status
Where the programme is now, and what comes next.
- Now
- Seed closed at hard cap. QUT strain optimisation under way; US market launch progressing.
Partners & sites Queensland University of TechnologyEra VC